Scandidos

Stockholm, April 11, 2014

NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in ScandiDos (SDOS) shares commenced today on First North at NASDAQ OMX Stockholm. ScandiDos belongs to the Health Care sector and is the eighth company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.

ScandiDos is headquartered in Uppsala, Sweden and has offices in USA and China. The company provides QA, quality assurance, and dosimetry for the modern radiation therapy. The company provides unique measurement systems and software that are designed for the requirements for QA and validation of the new dynamic and modulated treatments that is being implemented in clinics around the world.


Interview with the CEO, Görgen Nilsson (In English)


Görgen Nilsson, CEO at ScandiDos is welcomed by Marie Parck, NASDAQ OMX.  


Görgen Nilsson tolls the bell at the First North market opening.


From the left:  Per Carendi, Chairman, Ingemar Wiberg, vice president, Görgen Nilsson CEO at Scandidos and Håkan Sjögren, NASDAQ OMX. Also in the picture the ScandiDos machine for cancer treatment.


The ScandiDos team together with their certified adviser, Redeye and the NASDAQ OMX team.